Talk with a clinic navigator Call us +1 (800) 923-7404
TREATMENT GUIDE · OPTIONS TO EXPLORE

Biomarker testing for cancer treatment

Cancer treatment & testing

Established diagnostic tool for selected treatment decisions

Biomarker testing looks for features of a cancer, such as gene changes or proteins, that may help guide treatment. Testing may use tumor tissue, blood or another sample, depending on the question being asked. It can identify an approved treatment option, a clinical trial or a reason a particular drug is unlikely to help. It is a diagnostic tool rather than a treatment. Tumor testing is also different from testing inherited cancer risk, although findings can sometimes overlap.

Information checked 2026-09-29 View sources ↓
A PLACE TO BEGIN

About this approach

Biomarker testing looks for features of a cancer, such as gene changes or proteins, that may help guide treatment. Testing may use tumor tissue, blood or another sample, depending on the question being asked. It can identify an approved treatment option, a clinical trial or a reason a particular drug is unlikely to help. It is a diagnostic tool rather than a treatment. Tumor testing is also different from testing inherited cancer risk, although findings can sometimes overlap.

Where it fits: Established diagnostic tool for selected treatment decisions

CURRENT CLINICAL USE

Where this treatment is used

The usefulness of testing depends on the cancer, stage, test quality and the decisions it can inform. Some tests evaluate a single established marker; others examine many genes or proteins. A result may identify a well-supported treatment match, a research hypothesis or a change whose significance is uncertain. Not every detected alteration has an effective drug, and a matched drug may still fail to help. Tumors can also change over time, which may make repeat testing relevant. Blood-based testing can be useful in selected situations, but an uninformative result does not always exclude an actionable change. The team should explain which results are clinically established and whether additional tissue or inherited-risk testing is needed.

WHAT TREATMENT MAY INVOLVE

Procedure and practical considerations

Obtaining tissue can involve pain, bleeding, infection or organ-specific biopsy risks. Testing also brings possible costs, delays and uncertainty, including results that do not change treatment. Some findings may suggest an inherited change that needs separate confirmation and genetic counseling. Avoid changing treatment solely because a commercial report lists a drug; clinical context and the strength of supporting evidence matter.

EXPLORE YOUR OPTIONS

Clinics reporting this approach

These clinic profiles connect to this approach through clinic-confirmed selections or Cancer Clinic Finder’s source review. Open a profile to compare locations, services, practical details, and ways to get started.

3 connected profiles

Browse all 3 connected profiles
FOLLOW THE INFORMATION

Sources

Source information checked: 2026-09-29. The links below identify the public and clinic-provided materials used for this page.

  1. NCI: Biomarker Testing for Cancer Treatment ↗Checked 2026-09-29
  2. NCI: Tumor Markers ↗Checked 2026-09-29

How Cancer Clinic Finder compiles information · Suggest a factual correction

REQUEST A CALLBACK

Request a callback.

Tell us the best number to reach you. A clinic navigator will call to help you explore treatment centers.

This request goes to our team, not to a clinic. Please do not include medical records or sensitive health information.

+1 800 923 7404 What happens on the call ↗